No Data
No Data
Join OS Therapies' Exclusive Live Investor Webinar and Q&A Session on February 27
Express News | Os Therapies Inc - in Discussions to Form Joint Ventures With ADC Companies
OS Therapies Launches Subsidiary to Advance Tunable Antibody Drug Conjugates, Plans Stock Dividends for Shareholders
OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for Its Tunable ADC & Drug Conjugates Platforms
Express News | Os Therapies Forms Subsidiary Os Drug Conjugates and Initiates Review of Strategic Options for Its Tunable ADC & Drug Conjugates Platforms
OS Therapies Analyst Ratings
Unlock the Full List